tirzépatide effets secondaires MEDVASC Zepbound (tirzépatide) : Qu'est-ce que

Zepbound, the newly approved weight loss drug, hit the market this month

We pay particular attention to any contraindications, such as a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Last updated April 2026 Sources verified against the Zepbound FDA prescribing information, NEJM SURMOUNT-1 (Jastreboff et al., 2022), and Lillys Zepbound consumer page

This is why the manufacturer explicitly states that frozen pens should be discarded

Bioavailability tops the list

GLP-1s are no longer only useful for weight loss and diabetes they are critical for building metabolic resilience and reducing inflammation, making them a powerful component of whole-person, lasting health